Gene Query: MTMR9

Dataset Description Geneva Score
Assembly of methylated LSD1 and CHD1 drives AR-dependent transcription and translocation 141.15
Assembly of methylated LSD1 and CHD1 drives AR-dependent transcription and translocation [RNA-Seq] 141.15
Supraphysiological Androgens Repress Prostate Cancer Growth and Induce DNA Damage Augmented by PARP Inhibition 58.93
Role for citron kinase in prostate cancer growth 43.35
Contribution of SRF and Nkx2-5 to androgen-dependent gene expression in prostate cancer 34.35
Therapeutic targeting of KDM1A/LSD1 in Ewing sarcoma engages the ER-stress response II 27.29
Gene expression profiling of LNCaP cells following shRNA-mediated knockdown of TMEFF2 and growth in presence and absence of dihydrotestosterone 26.99
The regulartory role of ZCCHC24 in splicing machinery 25.84
Paxillin regulates genomic networks in prostate cancer [C4-2] 23.43
Differential expression of genes in AD169-infected MRC5. 22.6
ICE1 promotes the link between splicing and nonsense-mediated mRNA decay 18.4
RNA-Seq from early time points in the kidney differentiation protocol 18.23
Loss of CHD1 facilitates oncogenic hijacking of AR during cancer progression [RNA-seq] 17.63
Loss of CHD1 facilitates oncogenic hijacking of AR during cancer progression 17.63
Regulartory effect of HNRNPL and LARP on RNA expression in LNCaP prostate cancer cells 17.26
HNRNPL and its RNA Targets in Prostate Cancer 17.26
RNA-Seq profiling of days 0, 7 and 18 kidney organoids differentiated from three separate vials of starting material 15.7
Parkinson’s Disease Genetic Risk in a Midbrain Neuronal Cell Line 14.8
Forkhead domain mutations in FOXA1 drive prostate cancer cell progression 14.54
RNA-seq in LNCaP cell line overexpressing WT or mutant FOXA1 14.54
Differential expression of genes in HCMV-infected fibroblasts regulated by the purinergic receptor P2Y2. 14.15
AR-independent prostate cancer is sustained through FGF signaling 12.95
ZMYND8 reads the dual histone mark H3K4me1-H3K14ac to antagonize the expression of metastasis-linked genes 12.39
Studying the selectivity of a small molecule Synucleozid on transcriptome 12.34
In vitro differentiation of human low threshold mechanoreceptive (LTMR) neurons from embryonic stem cells 12.02
A TGFbeta-PRMT5-MEP50 Axis Regulates Cancer Cell Invasion through Histone H3 and H4 Arginine Methylation Coupled Transcriptional Activation and Repression 11.84
Cooperation of dominant oncogenes with regulatory variants shapes clinical outcomes in pediatric cancer 11.36
RNA-seq of three Ewing sarcoma cell lines (A673, SK-N-MC, RDES), transfected with either siControl or siMYBL2. 11.36
PHF20 readers link methylation of histone H3K4 and p53 with H4K16 acetylation 11.11
The human cellular nucleic acid binding protien binds G-rich elements close to translation initiation sires and promotes translation. 11.05
The human cellular nucleic acid binding protien binds G-rich elements close to translation initiation sires and promotes translation. [RNA-Seq] 11.05
Major hnRNP proteins act as general TDP-43 functional modifiers both in Drosophila and human neuronal cells. 10.42
Examining serotonergic neuron differentiation from human iPSCs 10.39
Glioma Stem Cell Specific Super Enhancer Drives Polyunsaturated Fatty Acid Synthesis to Support EGFR Signaling 10.04
MYT1 attenuates neuroblastoma cell differentiation by inhibiting retinoic acid signaling pathway 9.81
RG/RGG boxes are common binding motifs in RNA-G-quadruplex-interacting proteins 9.64
R430: A potent inbibitor of DNA and RNA viruses 9.41
FOXA1 Chromatin Binding is Regulated by LSD1-Mediated Demethylation 9.24
RNA-Seq with DHT induction and/or GSK treatment at 24, 48 hrs and 2 weeks 9.24
BET bromodomain inhibition 9.03
Effect of BET bromodomain inhibition with JQ1 in stressed human derived iPS cardiomyocytes 9.03
Human embryonic stem cells in E8 and AKIT culture medium 9.01
Growth factor-free, chemically-defined culture system for expansion and derivation of human pluripotent stem cells 9.01
Atheroprotective flow alters EZH2/H3K27me3 dependent transcriptional profile in human endothelial cells 9.01
BRG1 governs Glucocorticoid Receptor interactions with chromatin and pioneer factors across the genome 9.0
RNA-sequencing of fibrolamellar carcinoma (FLC) cell line treated with miR-375 mimic 8.97
Transcriptomic Profiling of Developing Human Paraxial Mesoderm from 4.5-5 Weeks of Gestation Human Embryos 8.84
mRNA cap methyltransferase, RNMT-RAM, promotes RNA pol II transcription 8.82
Quantitative comparison between cellular mRNAs and exosomal mRNAs in human iPSC-derived motor neurons 8.65
The Jumonji-domain histone demethylase inhibitor JIB-04 deregulates oncogenic programs and increases DNA damage in Ewing Sarcoma, resulting in impaired cell proliferation and survival, and reduced tumor growth 8.54
Post-transcriptional manipulation of TERC reverses molecular hallmarks of telomere disease 8.35
Neuroligin-4 Regulates Excitatory Synaptic Transmission in Human Neurons 8.28
RNA-sequencing analysis for gene expression profiles affected by CASC9 knockdown 8.23
Integrated multi-omics approach reveals a role of ALDH1A1 in lipid metabolism in human colon cancer cells 8.22
Codon usage optimization in pluripotent embryonic stem cells [RNA-seq] 8.2
Role of miR-146a in neural stem cell differentiation and neural lineage determination: relevance for neurodevelopmental disorders 8.2
Activation of neuronal genes via LINE-1 elements upon global DNA demethylation in human neural progenitors 8.17
Identification of global XBP1s target gene expression in human prostate cancer cells 8.16
RNA-Seq analysis of prostate cancer cell line LNCaP treated with vehicle, androgen, androgen and IMTPPE, androgen and JJ-(+)-450, androgen and JJ-(-)450, androgen and enzalutamide 8.08
The effect of doxycycline-induced expression of host-cell-factor 2 (HCF-2) proteins on the global gene expression in HEK-293 cells 7.92
Mutational landscape of splicing genes and functional consequences across 33 cancer types 7.69
Targeting the androgen receptor N-terminus via the cochaperone Bag-1L 7.47
SETDB2 links E2A-PBX1 to cell cycle dysregulation in acute leukemia through CDKN2C repression [sequencing] 7.42
Single-cell transcription profiling in KS1 patient iPSCs and NPCs 7.35
DDX3X regulation of global translation is impaired by medulloblastoma-associated mutations 7.34
DDX3X regulation of global translation is impaired by medulloblastoma-associated mutations [RNA-Seq] 7.34
Transcriptome analysis of U87 cells upon LINC00152 knockdown 7.33
Network-based, cross-cohort discovery of transcriptional mechanisms presiding over maintenance of high-risk neuroblastoma subtype state 7.24
RNA-Seq comparative analysis of human neuroblastoma cells before and after their confrontation to the embryonic microenvironment 7.23
Functional interactions between Mi-2β and AP1 complexes control response and recovery from barrier disruption 7.19
Transcriptional profile of CAOV2 ovarian cancer cells with TAZ silencing 7.17
Genomic basis for clinical response to histone deacetylase inhibition in advanced urothelial carcinoma 7.16
PolyA-sequencing in IMR-32 cells treated with THZ531 or DMSO 7.15
RNA-sequencing of human vascular endothelial cells after si-RNA mediated gene silencing of interleukin-6 (IL6) 7.13
ONECUT2 Drives Neuroendocrine Prostate Cancer Through Hypoxia Signaling 7.07
Analysis of regulatory element evolution between human and mouse reveals a lack of cis-trans compensation 6.95
IQGAP3 interacts with Rad17 to activate the MRN/ATM/Chk2 signaling and promote radioresistance in lung cancer 6.72
Human Cactin interacts with DHX8 and SRRM2 to assure efficient pre-mRNA splicing and sister chromatid cohesion. 6.63
Heterozygous and homozygous knock-in of PIK3CA-H1047R into human iPSCs 6.56
A novel P300 inhibitor reverses DUX4-mediated global histone H3 hyperacetylation, target gene expression and cell death 6.56
Tumor suppressor SMARCB1 suppresses super-enhancers to govern hESC lineage determination 6.48
JunB control of keratinocyte-mediated inflammation [RNA-seq] 6.47
RNA-Seq and ChIP-Seq reveals SQSTM1/p62 as a key mediator of JunB suppression of NF-kB-dependent inflammation 6.47
MLL-AF4 Spreading Identifies Binding Sites that Are Distinct from Super-Enhancers and that Govern Sensitivity to DOT1L Inhibition in Leukemia. 6.4
Global Promotion of Alternative Internal Exon Usage by mRNA 3' End Formation Factors 6.39
Global Regulation of Alternative Internal Exon Usage by mRNA 3' End Formation Factors [RNA-Seq] 6.39
IRF2 is a master regulator of human keratinocyte stem cell fate [RNA-seq] 6.3
IRF2 is a master regulator of human keratinocyte stem cell fate 6.3
Endogenous interaction profiling identifies DDX5 as an oncogenic coactivator of transcription factor Fra-1 [RNA-seq] 6.1
Endogenous interaction profiling identifies DDX5 as an oncogenic coactivator of transcription factor Fra-1 6.1
Induced pluripotent stem cell modeling of bone marrow failure and MDS identifies therapeutic targets 6.09
The effect of engineered del(7q) on induced pluripotent stem cells (iPSCs) derived from patients with Shwachman Diamond Syndrome (SDS). 6.04
Recapitulation of Human Neural Microenvironment Signatures in iPSC-Derived NPC 3D Differentiation 5.86
Dtx3L and Androgen Signaling in Prostate Cancer 5.84
The ZZ-type zinc finger of ZZZ3 modulates the ATAC complex-mediated histone acetylation and gene activation 5.8
Convergent roles of ATF3 and CSL in chromatin control of CAF activation 5.71
Convergent roles of ATF3 and CSL in chromatin control of CAF activation [RNA-seq] 5.71
Induction and Therapeutic Targeting of Human NPM1c+ Myeloid Leukemia in the Presence of Autologous Immune System in Mice 5.66
An Alternative Splicing Event Amplifies Evolutionary Differences Between Vertebrates 5.66
Identification of monocyte-like precursors of granulocytes as a mechanism for accumulation of PMN-MDSC in cancer 5.64
CREB5 promotes resistance to androgen-receptor antagonists and androgen deprivation in prostate cancer 5.63
Open chromatin mapping identifies transcriptional networks regulating human epididymis epithelial function 5.62
Open chromatin mapping identifies transcriptional networks regulating human epididymis epithelial function [Rnase-Seq] 5.62
PAK4 suppresses RELB to prevent senescence-like growth arrest in breast cancer 5.62
A Primate lncRNA Mediates Notch Signaling During Neuronal Development by Sequestering miRNA [SHSY5Y cells] 5.58
Mapping cis-regulatory chromatin contacts in neural cells links neuropsychiatric disorder risk variants to target genes [RNA-Seq] 5.57
Mapping cis-regulatory chromatin contacts in neural cells links neuropsychiatric disorder risk variants to target genes 5.57
DNA breaks and chromatin structural changes enhance the transcription of Autoimmune Regulator target genes 5.48
DNA breaks and chromatin structural changes enhance the transcription of Autoimmune Regulator target genes [RNA-Seq] 5.48
FUS mutant human motoneurons transcriptome analysis reveals altered pathways and impairment of microRNA function 5.46
Gene-Edited Human Kidney Organoids Reveal Mechanisms of Disease in Podocyte Development 5.45
MeRIP sequencing reveals angiogenic properties of vascular endothelial cells 5.41
Dual modulation of neuron specific microRNAs and the REST complex promotes functional maturation of induced human adult neurons 5.36
Dual inhibition of HDMX and HDM2 as a Therapeutic Strategy in Leukemia 5.33
Transcriptome profiling of self-renewing hESCs and multipotent mesoderm progenitor cells as a function of substrate stiffness 5.31
Studying iPSCs from a hibernating mammal reveals molecular mechanisms of cold resistance in neural tissues 5.3
The translation termination factor GSPT1 is a phenotypically relevant off-target of heterobifunctional phthalimide degraders 5.27
Transcriptome response to 4h IL-1b stimulation of primary chondrocytes 5.26
Non-transmissible measles virus vector with segmented RNA genome establishes different types of iPSCs from hematopoietic cells 5.25
Impact of dieldrin on transcription in Jurkat T cells 5.24
A peninsular structure coordinates asynchronous differentiation with morphogenesis to generate pancreatic islets [bulk vs buds] 5.15
RNA-seq analysis reveals profound changes in transcript profiles between siCon- and siH19-transfected EVT cells 5.12
CDK12 catalytic activity is rate-limiting for RNAPII processivity on core DNA replication genes and G1/S progression (3' RNA) 5.11
DUX4-induced histone variants H3.X and H3.Y mark DUX4 target genes for expression 5.1
DUX4-induced histone variants H3.X and H3.Y mark DUX4 target genes for expression (RNA-seq) 5.1
RNAseq analysis of ESRP regulated splicing events in prostate cancer 5.05
Tracing Enhancer Networks using Epigenetic Traits (TENET) 5.01
Distinct regulation of alternative polyadenylation and gene expression by nuclear poly(A) polymerases 4.99
Chronophin regulates metabolic and transcriptomic features of glioblastoma stem-like cells 4.91
Paxillin regulates genomic networks in prostate cancer [LNCaP] 4.86
Comparative principles of DNA methylation reprogramming during human and mouse in vitro primordial germ cell specification 4.81
Comparative principles of DNA methylation reprogramming during human and mouse in vitro primordial germ cell specification [Mouse and Human RNA-seq and BS-seq] 4.81
SLIGRL-induced gene expression changes in NHEK cells 4.76
DHX9 suppresses spurious RNA processing defects originating from the Alu invasion of the human genome [uvCLAP CLIP-seq] 4.73
Single-cell Transcriptomic Atlas of the Human Retina Identifies Cell Types Associated with Age-Related Macular Degeneration [Microfluidics] 4.71
Global transcriptional profiling changes upon knockdown of LKB1 in human glioblastoma cell lines 4.68
Peroxisome Proliferator-activated Receptor gamma- Deficiency in Endothelial Cells Impairs Angiogenic Capacity by Loss-of E2F1 Mediated Wnt Effector Genes 4.68
Genome-wide CRISPR-Cas9 screen identifies druggable synthetic lethality between LSD1 and MTORC1 in MLL-translocated AML 4.59
Smad5 acts as an intracellular pH messenger and maintains bioenergetic homoeostasis 4.58
Single-cell expression profiling reveals new roles for G-protein-coupled receptors in the regulation of Th17 pathogenicity 4.55
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression 4.55
BCL6 confers KRAS-mutant NSCLCs resistance to BET inhibitors 4.51
The regulation of ferroptosis by TAZ in epithelial ovarian cancer 4.46
miR941 overexpression experiment 4.44
Targeting the androgen receptor N-terminus via the cochaperone Bag-1L [RNA-Seq KO] 4.41
Modeling human brain evolution using induced pluripotent stem cells: comparative analysis of neuronal development in humans and chimpanzees 4.41
KSDM1b Role in Ewing Sarcoma 4.38
EZH2 and BCL6 cooperate to assemble CBX8-BCOR Polycomb complex to repress bivalent promoters, mediate germinal center formation and promote lymphomagenesis [RNA-seq] 4.33
EZH2 and BCL6 cooperate to assemble CBX8-BCOR Polycomb complex to repress bivalent promoters, mediate germinal center formation and promote lymphomagenesis 4.33
Derivation of kidney organoids from human pluripotent stem cells [RNA-Seq: Data Set 2] 4.31
Human iPSC-based Modeling of Late-Onset Disease using Progerin-induced Aging 4.3
mRNA gene expression profiling in a human AML cell line treated with small molecule inhibitors that impact different RNA polymerase transcription complexes, or their combination, in comparison to a global DNA-damaging anthracycline compound 4.28
Genome-wide Gene Expression Profiling in DLBCL Cell Lines Treated with CUDC-907 4.27
Cohesin and CTCF Differentially Affect the Chromatin Architecture and Gene Expression in Human Cells 4.27
BASP1 modifies the Tamoxifen response 4.26
Therapeutic targeting of GCB- and ABC-DLBCLs by rationally designed BCL6 inhibitors 4.25
Metabolic reprogramming of Kaposi’s sarcoma associated herpes virus infected B-cells in hypoxia 4.23
The RNA exosome nuclease complex regulates human embryonic stem cell differentiation [RNA-Seq rescue_SS] 4.19
A SRp55-regulated alternative splicing network controls pancreatic beta cell survival and function 4.19
The ribosomal prolyl-hydroxylase OGFOD1 decreases during cardiac differentiation, modulates translation and spliceosomal processes 4.18
Time-course expression data from HEK293∆RAF1:ER cells stimulated with 4OHT and labelled with 4SU 4.17
Time-course expression data from HEK293∆RAF1:ER cells stimulated with 4OHT, U0126, CYHX, ActD, EGF, FGF, or IGF and labelled with 4SU 4.17
Treatment Paradigms for Retinal and Macular Diseases Using 3-D Retina Cultures Derived From Human Reporter Pluripotent Stem Cell Lines 4.1
Antibody-Mediated Inhibition of MICA/B Shedding Promotes NK Cell-Driven Tumor Immunity 4.1
Tracking of dCas9-methyltransferase footprints 4.08
The RNA-binding profile of Acinus, a peripheral component of the Exon junction complex, reveals its role in splicing regulation 4.05
DNA Methylation Reprograms Metabolic Gene Expression in End-Stage Human Heart Failure 4.03
Understanding the reproducibility and robustness of the kidney organoid differentiation protocol using RNA-seq 4.02
Integrated Systems Biology Analysis of KSHV Latent Infection Reveals Viral Induction and Reliance on Peroxisome Mediated Lipid Metabolism 4.01
Grainyhead-like 2 is essential for androgen receptor expression and activity in prostate cancer (RNA-seq) 3.98
Grainyhead-like 2 is essential for androgen receptor expression and activity in prostate cancer 3.98
Region-specific Innate Antiviral Responses of the Human Epididymis 3.97
Integrating single-cell transcriptomic data across different conditions, technologies, and species 3.96
Comprehensive evaluation of differential gene expression analysis methods for RNA-seq data 3.94
In vitro modeling of human germ cell development using pluripotent stem cells 3.94
BET bromodomain proteins function as master transcription elongation factors independent of CDK9 recruitment [NET-seq] 3.94
Diverse Compounds from Pleuromutilin Lead to a Thioredoxin Inhibitor and Inducer of Ferroptosis 3.92
Genome-wide expression analysis of human hTert immortalized fibroblasts after downregulation of MCM2 3.89
Transcriptome of iPSC-derived Neural Cells with Heterozygous Knockout in CHD8 3.88
Synectin Promotes Fibrogenesis by Regulating PDGFR Isoforms Through Distinct Mechanisms 3.87
Identification of altered developmental pathways in human juvenile HD iPSC with 71Q and 109Q using transcriptome profiling 3.84
Landscape and variation of RNA secondary structure across the human transcriptome 3.84
RNA-seq of cells with TET1 knockout 3.83
Premature polyadenylation-mediated loss of stathmin-2 is a hallmark of TDP-43-dependent neurodegeneration 3.82
Obstructed defecation – an enteric neuropathy? An exploratory study of patient samples 3.8
Thymine DNA Glycosylase as a novel target for melanoma: effect of TDG silencing on gene expression in SK-mel-28 melanoma cells 3.79
Overexpression of UGT2B17 in MEC1 and JVM2 leukemia cell lines 3.78
Runx1 stabilizes the mammary epithelial cell phenotype and prevents epithelial to mesenchymal transition 3.76
Dual role of CSL (RBP-Jk) and NOTCH1 in CAF 3.75
Dual role of CSL (RBP-Jk) and NOTCH1 in cancer-associated fibroblast genome stability and expansion [RNA-seq] 3.75
Human iPSC-derived cells and microengineered Organ-Chip enhance neural development. 3.75
MicroRNA targetome analysis during HCMV infection 3.68
RNA Sequencing Facilitates Quantitative Analysis of Transcriptomes of H1, H1 derived APLNR+ cells, CD31+CD34+ cells and CD43+ cells during human early hematopoietic differentiation 3.67
RNA-seq analysis reveals profound changes in transcript profiles between siCon- and siH19-transfected uterine smooth muscle cells (USMC) 3.67
Click chemistry enables comprehensive preclinical evaluation of targeted epigenetic therapies [RNA-seq] 3.65
Click chemistry enables comprehensive preclinical evaluation of targeted epigenetic therapies 3.65
miCLIP, RNA-Seq, and Ribo-Seq in MOLM13 cells 3.64
Analysis of active enhancers and direct androgen receptor target genes in VCaP prostate cancer cells 3.63
Genome wide transcriptome analysis of palbociclib or GSK3326595 treated A375 cells [Palbociclib_GSK_RNASeq] 3.62
MEF2C phosphorylation is required for chemotherapy resistance in acute myeloid leukemia 3.61
Distinct and shared functions of ALS-associated TDP-43, FUS, and TAF15 revealed by comprehensive multi-system integrative analyses [RNA-Seq_human] 3.61
Metabolic Reprogramming Associated with Aggressiveness Occurs in the G-CIMP-High Molecular Subtypes of IDH1mut Lower Grade Gliomas 3.56
RNA sequencing of BT142 and TS603 cell lines 3.56
Binding to SMN2 pre-mRNA-Protein complex elicits specificity for small molecule splicing modifiers 3.55
Clinical and genomic crosstalk between glucocorticoid receptor and estrogen receptor α in endometrial cancer 3.54
Clinical and genomic crosstalk between glucocorticoid receptor and estrogen receptor α in endometrial cancer [RNA-seq] 3.54
Rna-seq transcriptome data for insulin-GFP+ cells differentiated from NEUROD1 knock out and NEUROD1+/+ control human embryonic stem cells. 3.51
NEUROD1 dependent gene regulation in murine pancreatic endocrine cells and human stem cell derived insulin producing cells 3.51
Next generation sequencing of the transcriptome in MCF-7 cells with/without SRA knockdown 3.5
Transcriptomic analysis of the effect of trastuzumab in human iPSC-CMs 3.49
Chromatin Topology Reorganization and Transcription Repression by PML/RARα in Acute Promyeloid Leukemia 3.49
Chromatin Topology Reorganization and Transcription Repression by PML/RARα in Acute Promyeloid Leukemia (RNA-seq) 3.49
GRHL2 is a key lineage determining factor which collaborates with FOXA1 to establish a targetable collateral pathway in the setting of endocrine therapy-resistant breast cancer (RNA-Seq data set 2) 3.47
Characterization of human mosaic Rett syndrome brain tissue by single-nucleus RNA sequencing 3.47
Glutaminolysis is a metabolic dependency in FLT3 ITD Acute Myeloid Leukemia unmasked by FLT3 Tyrosine Kinase Inhibition 3.45
Gene expression profiling of neural crest progenitor cultures derived from human embryonic stem cells carrying nonsense mutations in the Polycomb gene ASXL1 [HET] 3.4
Bromodomain inhibition of the co-activators CBP/EP300 facilitates reprogramming (RNA-seq fibroblasts) 3.39
Bromodomain inhibition of the co-activators CBP/EP300 facilitates reprogramming 3.39
Effects on gene expression of ibrutinib treatment in human stem cells-derived atrial- and ventricular-like cardiomyocytes 3.37
GREB1 amplifies androgen receptor output in prostate cancer and contributes to antiandrogen resistance 3.37
The p30 isoform of CEBPA uncovers a silent enhancer to drive the expression of the tumor promotive factor CD73 in CEBPA mutant AML 3.35
Transcriptional Targeting Of Oncogene Addiction In Medullary Thyroid Cancer 3.34
Transcriptional Targeting Of Oncogene Addiction In Medullary Thyroid Cancer [RNA-Seq] 3.34
Definition of Natural Killer cell heterogeneity in humans and mice by high-throughput single-cell RNA sequencing 3.33
RNAseq in Alzheimer's Disease patients 3.3
RNA-seq analysis of RALD iPSCs after in vitro differentiation 3.29
CD95L derived si- and shRNAs and the CD95L mRNA kill cancer cells through an RNAi mechanism by targeting survival genes [siL3.RNAseq.lg] 3.21
Primary Human B-cell Temporal Response to CD40L Stimulation 3.21
Bromodomain and extraterminal proteins foster the core transcriptional regulatory programs and confer vulnerability in liposarcoma 3.21
Bromodomain and extraterminal proteins foster the core transcriptional regulatory programs and confer vulnerability in liposarcoma (RNA-Seq) 3.21
Modulation of ESRP2 and MBNL2 in normal kidney and clear cell renal cell carcinoma cell lines for analysis of stability programs 3.21
Ewing sarcoma resistance to SP-2509 is not mediated through KDM1A/LSD1 mutation I 3.18
Transcription-dependent control of stem cell self-renewal and differentiation by the splicing factor U2AF1 3.18
Exploiting Prmt5-orchestrated intron detention signatures to treat splicing-addicted malignant glioma tumors 3.18
RNA-Seq analysis of human lung fibroblasts exposed to TGF-β 3.18
The DNM3OS lncRNA is a reservoir of fibromiRs with major functions in fibroblast response to TGF-beta and fibrogenesis 3.18
RNASeq of 4SU labelled nascent RNA in MV4;11 cell treated with DMSO, I-BET, SGC0946 and combination of I-BET and SGC0946 3.18
Selective suppression of endothelial cytokine production by progesterone receptor 3.17
Selective suppression of endothelial cytokine production by progesterone receptor [RNA-seq] 3.17
Comparison of expression profiles of APP-depleted prostate cancer cells (LNCaP) 3.17
A genome-wide long noncoding RNA CRISPRi screen identifies PRANCR as a novel regulator of epidermal homeostasis 3.15
CASZ1 directly regulates expression of myogenic genes through regional epigenetic modifications to induce muscle and rhabdomyosarcoma cell differentiation 3.14
Landscape of human mast cell chromatin: a rich resource for identification of novel mediators and genetic drivers of allergic and inflammatory diseases 3.13
Transcriptomic profiling of human CD34+ derived mast cells [RNA-Seq] 3.13
The Polycomb protein BMI1 induces an invasive gene expression signature in melanoma that promotes metastasis and chemoresistance. 3.09
DGCR8 acts as a novel adaptor for the exosome complex to degrade double-stranded structured RNAs 3.09
Oncogenic roles of ARID5B in T-ALL 3.03
RNA-seq analysis in knockdown Jurkat samples for each factor of TAL1 complex 3.03
Nucleotide stress induction of HEXIM1 suppresses melanoma by modulating cancer cell-specific gene transcription [RNA-Seq2] 3.02
HIV-1 perturbs homeostatic ILCs, unmasks ILC1 plasticity, and boosts TCF7+ memory NK cells 2.96
Self-organized cerebral organoids with human specific features predict effective drugs to combat Zika virus infection 2.93
Self-organized cerebral organoids with human specific features predict effective drugs to combat Zika virus infection [RNA-seq] 2.93
RNA-Seq characterization of human H1-derived NPC differentiation timecourse 2.93
Analyzing the interactions of mRNAs, miRNAs, lncRNAs and circRNAs to predict competing endogenous RNA networks in glioblastoma 2.92
IL-33 activates tumor stroma to promote intestinal polyposis 2.91
Luminal subtype-specific circRNAs in breast cancer cells by a novel tool for external data analysis. 2.89
a-synuclein accumulation in an iPSC derived model of early onset sporadic Parkinson’s Disease reveals novel drug targets 2.89
Restoration of Progranulin Expression Rescues Cortical Neuron Generation in Induced Pluripotent Stem Cell Model of Frontotemporal Dementia 2.87
Increased Serine and One Carbon Pathway Metabolism by PKCl/i Deficiency Promotes Neuroendocrine Prostate Cancer [RNA-seq] 2.86
Increased Serine and One Carbon Pathway Metabolism by PKCl/i Deficiency Promotes Neuroendocrine Prostate Cancer 2.86
Role of COP1 on MAP kinase transcriptional output in melanoma 2.86
To identify transcripts that are differentially expressed in the MYCN amplified vs MYCN non-amplified cell lines using Next Generation Sequencing 2.79
The ALK downregulated target gene HBP1 and repressor of MYCN activity as synergistic target for combined PI3K/HDAC inhibition 2.77
The ALK downregulated target gene HBP1 and repressor of MYCN activity as synergistic target for combined PI3K/HDAC inhibition [RNA-Seq] 2.77
CRISPR adenine and cytosine base editors with reduced RNA off-target activities 2.77
CRISPR adenine and cytosine base editors with reduced RNA off-target activities [CBE] 2.77
An epigenetic mark of polycomb response elements implemented by Trx/MLL/COMPASS 2.72
Plasma cell mitochondrial pyruvate import controls the duration of humoral immunity. 2.72
Widespread backtracking by RNA pol II is a major effector of gene activation, 5’ pause release, termination and transcription elongation rate 2.71
iPSC derived motor neuron cultures from C9ORF72 carriers 2.7
TOP2B disturbed the quality of human oocytes with advanced maternal age 2.68
Transcriptome analysis of diverse cell types infected with human cytomegalovirus [RNA-Seq] 2.68
Pan-cancer transcriptomic analysis associates long non-coding RNAs with key mutational driver events 2.68
An optimization system for isolating and sequencing of single human colon cancer cells 2.67
RNA-seq of naive and primed ES cells (NHSM) 2.66
RNAseq of CD8+ and CD8- MAIT cells in human peripheral blood 2.64
Gene expressions of H9s in different culture systems 2.61
hsa-miR-503, hsa-miR-103, and hsa-miR-494 genome wide target profiles [RNA-Seq and RIP-Seq] 2.61
Genome-wide hsa-miR-503, hsa-miR-103, and hsa-miR-494 target profiles 2.61
Epigenetic reprogramming of immune cells in women with PCOS impact genes controlling reproductive function 2.6
Epigenetic reprogramming of immune cells in women with PCOS impact genes controlling reproductive function [RNAseq] 2.6
SHANK2 mutations associated with autism spectrum disorder cause hyperconnectivity of human neurons 2.58
Transcriptome analysis of SH-SY5Y cells after knockdown of circSLC45A4 2.57
Total RNA-seq in ALL-SIL upon TLX1 knockdown 2.56
Lipid degradation promotes prostate cancer cell survival 2.56
MYCL and EP400 are required for Max and MCPyV mediated gene activation 2.56
Transcriptomic profiling of human peripheral blood-derived mast cells 2.54
Genome-wide analyses of chromatin state in human mast cells reveal molecular drivers and mediators of allergic and inflammatory diseases 2.54
Systematic Functional Perturbations Uncover a Prognostic Genetic Network Driving Human Breast Cancer 2.52
Systematic Functional Perturbations Uncover a Prognostic Genetic Network Driving Human Breast Cancer [RNA-Seq] 2.52
Differentially expressed genes during pancreatic bud differentiation in cellular aggregates 2.52
The immediate impact of exoribonucleolysis on nuclear RNA processing, turnover and transcriptional control revealed by rapid depletion of DIS3, EXOSC10 or XRN2 from human cells 2.52
RNA-SEQ assay for wild type and CRISPR induced endoglin knockout human pulmonary artery smooth muscle cells (PASMC) 2.5
Transcriptomic alterations in fibroblasts from Parkinson's disease patients carrying Parkin mutations 2.5
ARID1A and PI3-Kinase pathway mutations in the endometrium drive epithelial transdifferentiation and collective invasion 2.48
Transcriptome analysis reveals determinant stages controlling human embryonic stem cell commitment to neuronal cells 2.46
Knockout of miR-221 and miR-222 reveals overlapping and specific function between paralogous miRNAs 2.46
Expression profile of GIST48 cells with siETV1 or siFOXF1 knockdown 2.44
FOXF1 defines the core-regulatory circuitry in gastrointestinal stromal tumor (GIST) 2.44
hESC neural differentiation 2.43
RNA-seq analysis of gene expression patterns during hESC neural differentiation 2.43
The anti-leukemic effect of R-2HG depends on its acting as an m6A mRNA modifier-RNA Seq-PBS / R-2HG treatment 2.42
Transcriptomic and Epigenomic analysis of Huntington's disease and control patient iPSC-derived neural cells 2.4
mRNAseq of Huntington's disease and control patient iPSC-derived neural cells 2.4
Global Transcriptional analysis of human spinal cord and neocortical neuroepithelial stem (NES) cells 2.38
DRB/GRO-Seq -/+ UV 2.35
4sU-seq of HFF exposed to salt and heat stress 2.33
Dioxin and AHR impairs mesoderm gene expression and cardiac differentiation in human embryonic stem cells (RNA-Seq) 2.32
Dioxin and AHR impairs mesoderm gene expression and cardiac differentiation in human embryonic stem cells 2.32
Non-coding and coding transcriptional profiles are significantly altered in pediatric Retinoblastoma tumors 2.32
nELAVL HITS-CLIP in Alzheimer's Disease patients 2.31
SLAM-seq for K562 endogenous mRNA decay 2.31
FBP2 inhibits sarcoma progression by restraining mitochondrial biogenesis 2.3
Stage-specific regulation of the WNT/β-catenin pathway enhances differentiation of hESCs into hepatocytes 2.27
The transcriptome and chromatin accessbility landscape of mammalian germline 2.26
Whole transcriptome profile of citrulline-specific B cells from patients with rheumatoid arthritis 2.26
LINE-2 transposable elements are a source of functional human microRNAs and target sites 2.25
CRISPR activation of long non-coding RNAs transiently expressed during cortical neuron differentiation associated with Field, et al, Stem Cell Reports 2018 2.25
Improving fibroblast characterization using single-cell RNA sequencing: an optimized tissue disaggregation and data processing pipeline 2.24
Epigenetic reprogramming of melanoma cells by vitamin C treatment 2.2
Effect of PRDM11 depletion in U2932 cells 2.19
Transcriptome sequencing wide functional analysis of human mesenchymal stem cells 2.18
Gene expression regulated by CSA and CSB in neuroblastoma cell line 2.16
FGF2 regulation of gene expression in stable inducible Neurons 2.14
Critical role of transient activation of human endogenous retroviruses during reprogramming toward pluripotency 2.11
Critical role of transient activation of human endogenous retroviruses during reprogramming toward pluripotency (RNA-Seq) 2.11
Histone acetyltransferase p300 induces de novo super-enhancers to drive cellular senescence 2.1
Histone acetyltransferase p300 induces de novo super-enhancers to drive cellular senescence [RNA-seq] 2.1
Genome-wide maps of WT and over-expressing CenH3/CENP-A in Human HeLa S3 cells 2.1
Identification of transcripts altered upon LIN-41 knockdown in human embryonic stem cells 2.09
RNA binding protein CPEB1 remodels host and viral RNA landscapes [RNA-Seq] 2.05
ChIP-seq and RNA-seq analysis of KMT2D-silenced metastatic melanoma cells 2.05
Newly defined ABCB5+ dermal mesenchymal stem cells promote healing of chronic iron overload wounds via secretion of interleukin-1 receptor antagonist 2.0
Effect of venetoclax, tedizolid, and combination treatment on gene expression in a venetoclax-resistant AML cell line 2.0
Single-cell analysis of adult human ovary using 10X genomics 2.0
Deciphering H3K4me3 Broad Domains Associated With Gene Regulatory Networks and Conserved Epigenomic Landscapes in the Human Brain 2.0
Deciphering H3K4me3 Broad Domains Associated With Gene Regulatory Networks and Conserved Epigenomic Landscapes in the Human Brain [RNA-Seq] 2.0
RNA-Seq data for five HER2 over-expressed samples with twelve green fluorescent protein control samples using human mammary epithelial cells 2.0
RNA sequencing of heart samples of myotonic dystrophic (DM1) patients 1.99
DHX36 resolves G-rich structures in mRNA untranslated region to allow their translation [ChrRNA-seq] 1.98
Dynamic epigenetic remodeling underlies microRNA-mediated transdifferentiation of human adult fibroblasts into neuronal subtypes 1.98
Transcriptome of human ILC2s; primary vs IL-1b-primed 1.95
Total RNA profiles associated with DDX3 wild-type (WT) or R534H variant expression with or without sodium arsenite treatment [RNA-seq] 1.95
Profiles of ribosome-associated mRNAs regulated by expression of wild-type (WT) or R534H variant of DDX3 with or without Sodium Arsenite treatment 1.95
Regulation of Cell Cycle to Stimulate Adult Cardiomyocyte Proliferation and Cardiac Regeneration 1.94
Induction of Cardiomyocyte Proliferation [pz-822_human] 1.94
Loss of Nuclear TDP-43 Is Associated with Decondensation of LINE Retrotransposons 1.93
Loss of Nuclear TDP-43 Is Associated with Decondensation of LINE Retrotransposons [RNA-Seq] 1.93
Transcriptome-wide analysis to determine miR-200a targets in melanoma cell lines 1.93
Analysis of transcrptomes of Danon patient derived hiPSC-cardiomyocytes by RNA-deep Sequencing 1.88
Group A Streptococcus M1T1 Intracellular Infection of Primary Tonsil Epithelial Cells Dampens Levels of Secreted IL-8 Through the Action of SpyCEP 1.88
The metabolome regulates the epigenetic landscape during naïve to primed human embryonic stem cell transition 1.86
LncRNA DEANR1 facilitates human endoderm differentiation by activating FOXA2 expression 1.86
RNA sequencing to study transcriptomic changes in DLD-1 (colorectal adenocarcinoma) cells exposed to soft polyacrylamide matrices (~2 kPa and ~55 kPa) for short time scale of 90 minutes 1.84
Genome-scale screens identify JNK/JUN signaling as a barrier for pluripotency exit and endoderm differentiation 1.83
Transcriptome data of temporal and cingulate cortex in the Rett syndrome brain 1.82
Human germ cell formation in xenotransplants of induced pluripotent stem cells carrying X chromosome aneuploidies 1.8
single cell RNA-seq from Purkinje cell (ENCSR888LYA) 1.76
Identification of a LIF-responsive replication-competent human β cell 1.75
Stem cell and neurogenic gene-expression profiles link prostate basal cells to aggressive prostate cancer 1.75
Control of gene expression in senescence through transcriptional read-through of convergent protein-coding genes 1.74
The antineoplastic drug, trastuzumab, dysregulates metabolism in iPSC derived cardiomyocytes. 1.72
Isogenic patient-derived human iPSCs, wild-type or heterozygous for PIK3CA-E418K 1.72
Adenovirus Small E1A Employs the Lysine Acetylases p300/CBP and Tumor Suppressor Rb to Repress Select Host Genes and Promote Productive Virus Infection [RNA-seq] 1.68
Adenovirus Small E1A Employs the Lysine Acetylases p300/CBP and Tumor Suppressor Rb to Repress Select Host Genes and Promote Productive Virus Infection 1.68
RAID allows multiplexed quantification of intracellular (phospho-)proteins and transcriptomes from fixed single cells 1.67
Transcriptional effect of ETV1 knockdown in melanoma cells 1.62
Small-molecule targeting of brachyury transcription factor addiction in chordoma 1.61
Comparison of single-cell transcriptomics quality between unfixed cells and cells that were fixed and mock stained according to the RAID procedure 1.54
Transcriptome analyses of iPSC-derived neural stem/progenitor cells and cerebral organoids from monozygotic twins discordant for schizoaffective bipolar disorder 1.53
GRO-seq from HCT116, MCF7 and SJSA cell lines treated with DMSO and Nutlin 1.53
Identification of a core p53 transcriptional program with highly fractionated tumor suppressive activity 1.53
Cell cycle positioning drives heterogeneity within the pluripotent stem cell compartment 1.52
Differentiation of Induced Pluripotent Stem Cells towards Mesenchymal Stromal Cells is Hampered by Culture in 3D Hydrogels 1.52
Differentiation of Induced Pluripotent Stem Cells towards Mesenchymal Stromal Cells is Hampered by Culture in 3D Hydrogels [RNA-Seq] 1.52
Early transcriptome profiling of microRNA-mediated neuronal reprogramming [RNA-seq timecourse] 1.52
RNA-seq in neurons derived from iPSCs in controls and patients with schizophrenia and 22q11 del 1.51
Characterization of human mosaic Rett syndrome brain tissue by single-nucleus RNA sequencing (Total RNA sequencing) 1.5
Splicing function of mitotic regulators links R-loop mediated DNA damage to tumor cell killing 1.49
Transciptome profiling of NoDice and RNaseIII null cells prior to and after polyIC treatment 1.47
Networks of cultured iPSC-derived neurons reveal the human synaptic activity-regulated adaptive gene program 1.36
RNA-Seq of LRRK2 G2019S Parkinson’s iPSC-derived astrocytes 1.3
Efficient and precise editing of endogenous transcripts with SNAP-tagged ADARs 1.29
Transcriptome analysis in a radiosensitive and a radioresistant cell line after ionizing radiation 1.29
Mapping of DHT-responsive or -independent AR-binding sites induced by activated Src in prostate cancer cell lines [RNA-seq] 1.28
Mapping of DHT-responsive or -independent AR-binding sites induced by activated Src in prostate cancer cell lines 1.28
Next Generation Sequencing Facilitates Comparisons of Control and Schizophrenia-Patient derived hiPSC-derived neurons 1.28
The transcription and translation landscapes during human cytomegalovirus infection reveal novel host-pathogen interactions 1.27
Polycomb- and Methylation-Independent Roles of EZH2 as a Transcription Activator 1.19
Polycomb- and Methylation-Independent Roles of EZH2 as a Transcription Activator [RNA-seq] 1.19
Characterisation of HIF-dependent alternative isoforms in pancreatic cancer 1.19
Time series total RNA sequencing of a differentiation of human embryonic stem cells towards trophoblast lineage 1.18
Transcriptome-wide discovery of microRNA binding sites in human brain by Ago2 HITS-CLIP 1.17
single cell RNA-seq from GM12878 (ENCSR673UIY) 1.14
Activation Dynamics and Immunoglobulin Evolution of Pre-existing and Newly Generated Human Memory B-cell Responses to Influenza Hemagglutinin 1.13
Identification of biomarkers for amyotrophic lateral sclerosis by comprehensive analysis of exosomal mRNAs in human cerebrospinal fluid. 1.1
O-glcnAc reprograms cellular energetics 1.1
Pseudouridylation of tRNA-derived fragments steers translation control in stem cells [Polysome-Seq] 1.08
The dynamic landscape of coding and non-coding RNAs in the innate immune response to microbial pathogens 1.08
RNA-seq after siRNA targeting DDX24 applied to iHUVECs cell lines 1.05
Epigenetic profiling and RNA-sequencing of Juvenile Idiopathic Arthritits (JIA) patients 1.05
RNA-sequencing of cells derived from the site of inflammation of Juvenile Idiopathic Arthritis patients 1.05
Osmostress induced changes of chromatin architecture and transcription in mammalian cells [RNA-Seq, HiC] 1.04
Osmostress induced changes of chromatin architecture and transcription in mammalian cells 1.04
12hr 5-FU treatment vs. DMSO in SJSA cells (from 'A kinase independent role for CDK19 in p53 response') 1.04
Genomic profiling of human spermatogonial stem cells [BulkRNA-Seq] 1.0
Transcriptome analysis of diverse cell types infected with human cytomegalovirus 0.97
NOTCH signaling is activated in and contributes to resistance in enzalutamide-resistant prostate cancer cells 0.97
Small-molecule targeting of brachyury transcription factor addiction in chordoma [rnaseq_compound] 0.94
RNA-seq and ChIP-seq analysis of BMI1 or RING1B-silenced prostate cancer cells C4-2 0.93
Gene expression analysis of human haploid cells (HAP1) depleted of SMARCB1 and SMARCA4 0.88
Dissecting cell composition and cell-cell interaction network of normal human heart tissue by single-cell sequencing 0.88
Gene expression analysis of CD4+ and CD4- ILC1 subsets by RNAseq 0.86
Tracing transcriptome profiles of human oocyte cultured by growth hormone or not in vitro by single cell RNA-seq 0.85
The age and genomic integrity of neurons after cortical stroke in humans 0.82
Cis-SAGe fusion RNAs in transcription splicing factors knocking-down 293T cells 0.79
Cleavage Factor Im as a key regulator of 3’ UTR length 0.78
RNA-seq analysis of PRMT5-regulated genes in irradiated/non-irradiated LNCaP cells 0.78
Single cell transcriptomics analysis of induced pluripotent stem cell-derived cortical neurons reveals frequent dual layer identity 0.75
The chromatin modifier CHD8 targets autism risk genes during human neurodevelopment  0.74
Epigenomic conservation of transposable element silencing [RNA-seq] 0.71
Epigenomic conservation of transposable element silencing 0.71
Replication defective viral products exploit a cellular pro-survival mechanism to establish persistent infections 0.69
Subclonal cooperation drives metastasis through modulating local and systemic immune microenvironments 0.68
LMO1 Synergizes with MYCN to Promotes Neuroblastoma Initiation and Metastasis 0.66
Genome-wide RNA-sequencing (RNA-seq) of benign and malignant prostate cell lines without and with androgen (R1881) stimulation. 0.65
Progressive motor neuron pathology and the role of astrocytes in a human stem cell model of VCP-related ALS 0.64
N6-methyladenine DNA Modification in Glioblastoma [RNA-seq] 0.63
N6-methyladenine DNA Modification in Glioblastoma 0.63
c-Jun promotes cell migration and drives expression of the motility factor ENPP2 in soft tissue sarcomas 0.62
c-Jun promotes cell migration and drives expression of the motility factor ENPP2 in soft tissue sarcomas [RNA-Seq] 0.62
RNA expression profiles from HUVECs overexpressing adenovirally delivered HIF1a and HIF2a proteins 0.61
Progesterone Receptor- and FOXO1-dependent transcriptomes decidualized human endometrial stromal cells 0.61
FOXO1 is required for binding of PR on IRF4, novel transcriptional regulator of endometrial stromal decidualization 0.61
Progesterone receptor transcriptome and cistrome in decidualized human endometrial stromal cells 0.61
Expression profiling of ILC transitional populations and Aiolos accessability and H3K27ac histone modifications in transfected MNK3 cells 0.6
RNA-Seq from human ILC transitional populations 0.6
Activity-dependent transcriptional changes in human neurons 0.6
Effect of low-dose sorafenib and alkylating agents in inflammation and angiogenesis in breast cancer 0.6
Evaluating and comparing the Transcriptome of (human) Hek 293 based cells, expressing either CHD3 or CHD4 0.59
Mitochondrial unfolded protein response controls matrix pre-RNA processing and translation 0.58
Next generation sequencing of small RNAs isolated from exosomes in human semen 0.57
TT-seq captures simultaneous activation of eRNAs and promoters during T cell activation 0.57
A Non-Canonical Nuclear Activity Triggered by Small RNAs and Argonaute Proteins in Human Cells 0.57
Global Long Terminal Repeat activation participates in establishing the unique gene expression program of classical Hodgkin Lymphoma [RNA-Seq] 0.56
ALS implicated protein TDP-43 sustains levels of STMN2 a mediator of motor neuron growth and repair 0.55
Hyper-excitability of Neurons generated from Patients with Bipolar Disorder 0.55
WNT signaling memory is required for ACTIVIN to function as a morphogen 0.54
MEF2C phosphorylation is required for chemotherapy resistance in acute myeloid leukemia [inhibitor MRT199665] 0.53
Dilated cardiomyopathy vs Myocarditis 0.52
T47D xenografts treated with various combinations of ER- and PR-targeting therapies 0.52
Long non-coding RNA TYKRIL controls pericyte function and survival in the cardiovascular and central nervous system through regulation of p53 activity and PDGFRß expression 0.45
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression [NALM6 RNA-Seq] 0.4
Entrectinib Resistance in a Neuroblastoma Xenograft Model 0.37
Primate-specific gene TMEM14B promotes cortical expansion and folding 0.37
Distinct and shared functions of ALS-associated TDP-43, FUS, and TAF15 revealed by comprehensive multi-system integrative analyses [RNA-Seq_Stability] 0.36
Pre-clinical evaluation of cysteamine bitartrate as a therapeutic agent for mitochondrial respiratory chain disease (human) 0.36
Pre-clinical evaluation of cysteamine bitartrate as a therapeutic agent for mitochondrial respiratory chain disease 0.36
A comprehensive single cell transcriptional landscape of human hematopoietic progenitors 0.34
Sex-specific gene expression differences are evident in human embryonic stem cells and during in vitro differentiation of human placental progenitor cells 0.33
Targeting Glioblastoma Stem Cells through Disruption of the Circadian Clock 0.33
Targeting Glioblastoma Stem Cells through Disruption of the Circadian Clock [RNA-Seq] 0.33
Coronary artery disease genes SMAD3 and TCF21 promote opposing interactive genetic programs that regulate smooth muscle cell differentiation and disease risk [RNA-seq] 0.32
Coronary artery disease genes SMAD3 and TCF21 promote opposing interactive genetic programs that regulate smooth muscle cell differentiation and disease risk 0.32
Generation and persistence of human tissue-resident memory T cells in lung transplantation 0.32
A large panel of isogenic APP and PSEN1 mutant human iPSC neurons reveals shared endosomal abnormalities mediated by APP b-CTFs, not Ab [RNA-seq] 0.31
Neuronal brain region-specific DNA methylation and chromatin accessibility are associated with neuropsychiatric trait heritability [RNA-Seq] 0.3
Neuronal brain region-specific DNA methylation and chromatin accessibility are associated with neuropsychiatric trait heritability 0.3
Transcriptome-wide off-target RNA editing induced by CRISPR-guided DNA base editors [Modifications - screen] 0.3
PolyA-sequencing in IMR-32 neuroblastoma cells with shRNA mediated depletion of CDK12, CDK13 or GFP. 0.29
Transcriptomics analysis of gene expression in normal and YTHDC1, SRSF1, SRSF3, SRSF7, SRSF9 or SRSF10 deficient human HeLa cells 0.28
The novel lncRNA lnc-NR2F1 is pro-neurogenic and mutated in human neurodevelopmental disorders [lnc-Nr2f1 overexpression] 0.24
The novel lncRNA lnc-NR2F1 is pro-neurogenic and mutated in human neurodevelopmental disorders 0.24
Genome-wide analysis of the Integrator complex 0.24
Genome-wide analysis of the Integrator complex (HTS) 0.24
Transcriptome of iPSC-derived Cerebral Organoids with Heterozygous Knockout in CHD8 0.23
The WNT target SP5 negatively regulates WNT transcriptional programs in human pluripotent stem cells 0.2
TCF21 and Aryl-hydrocarbon receptor gene cooperate to activate a pro-atherosclerotic gene expression program 0.18
4C-seq of insulin promoter, knockdown of INS promoter activity and Genome-wide maps of chromatin state in EndoC-βH1 Cells 0.16
Viral shRNA Knockdown of INS Promotor Activity in EndoC-βH1 Cells  0.16
Transcriptome-wide discovery of microRNA binding sites in human brain by Ago2 HITS-CLIP [Ago2-miRNA-target mRNA complexes] 0.16
A20 regulates canonical wnt-signaling through an interaction with RIPK4 0.16
Regulation of the glucocorticoid receptor via a BET-dependent enhancer drives antiandrogen resistance in prostate cancer 0.16
The control of rRNA synthesis during the directed differentiation of human embryonic stem cells precedes heterochromatin formation. 0.15
Sodium butyrate ameliorates aSyn-induced transcription deregulation and DNA damage 0.15
Arnica montana stimulates extracellular matrix gene expression in human macrophages differentiated to wound-healing phenotype. 0.14
Downregulation of LATS kinases alters p53 to promote cell migration 0.13
TNFα Signaling Exposes Latent Estrogen Receptor Binding Sites in Breast Cancer Cells [GRO-seq] 0.12
TNFα Signaling Exposes Latent Estrogen Receptor Binding Sites in Breast Cancer Cells 0.12
Critical role for Lymphocytes in Producing FLT3LG in Tumors and Driving Checkpoint Therapy-Receptive Immune Microenvironments 0.09
Single-cell transcriptomics of human oocytes: environment-driven metabolic competition and compensatory mechanisms during oocyte maturation 0.09
Transcriptome of EBV-infected gastric cancer cell lines 0.05
RNA-sequencing of the brain transcriptome implicates dysregulation of neuroplasticity, circadian rhythms, and GTPase binding in bipolar disorder 0.04
mRNA-sequencing of 293T-no dice transfected with miR-16, miR-214, or KSHV-miR-K6-5p 0.04
RNA-Seq of human induced pluripotent stem cell-derived cardiomyocytes from a cardiomyopathy patient and familial control 0.04
FOXP1 orchestration of ASD-relevant signaling pathways. 0.03
Total RNA-Seq data from leukemic patients with complex structural variants 0.01
Transcriptional landscape changes during human embryonic stem cell derivation 0.01
RNA-seq of HUVEC ± shRNA knockdown of SENCR 0.0
RNA-seq and small RNA-seq from WT and ADAR1 knockdown H9 lines and their differentiation to specific types of neurons 0.0


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation